Locations
England, UK · London, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Biotechnology
Size
11-50 employees
Stage
Other
founded in
2019
Autolomous is a company founded by cell and gene therapy (CGT) and software development experts, who have combined their skills to deliver elegant, seamless, and agile solutions to the CGT sector. Autolomous will deliver the digital solutions necessary for CGT to achieve scalability, allowing more patients to benefit from these life-changing therapies. The company is creating a portfolio of software solutions (Autolomate-Solution Platform), from electronic batch manufacturing records (EBMR) to enabling the scheduling of the patient blood collections at hospitals; the transport of those cells to the manufacturing facilities; enhancing traceability throughout the manufacturing process; supporting compliance with current and future regulatory requirements; expediting the drug product release; and the scheduled delivery of the patient-specific medicine to the hospital. Our software will enable increased automation of these processes, reducing the risk of errors and ensuring that the correct product is returned to the right patient. Autolomate has been architected with agility, flexibility, and adaptability in mind both for our customers for customization but also for our partners to integrate with our platform to create an end-to-end digital ecosystem. We’re looking for new team members. Are you a forward-thinking, digitally-minded individual? Do you want to be part of a meaningful and value-oriented company? Get in touch!
Something looks off?